The Recall Desk
CriticalFDA (Drugs)·D-0340-2018·Announced 2018-02-14

AuroMedics Recalls Pantoprazole Sodium Injection Due to Glass Particulate

AuroMedics Pharma LLC is recalling 66,100 vials of Pantoprazole Sodium for Injection because one vial contained a piece of glass.

What this means for you

Highest-severity recall. Risk of serious injury or death is documented or strongly suspected. Stop using the product now and follow the agency's instructions.

Our severity reasoning: The recall is classified as FDA Class I, which meets the rubric criteria for a Critical severity score of 5.

Plain-English summary

AuroMedics Pharma LLC is recalling 66,100 vials of Pantoprazole Sodium for Injection, 40 mg per vial, single dose vial, Rx only. The product is manufactured in India for AuroMedics Pharma LLC and carries NDC 55150-202-00. The specific lot number is CPO170035.

The recall was initiated because one vial from the lot was found to contain a piece of glass. This is a Class I recall, which indicates a reasonable probability that use of the product may cause serious adverse health consequences or death.

The product was distributed nationwide in the USA. Patients and healthcare providers should stop using the recalled product and contact their healthcare provider or pharmacist for guidance on alternative treatments or replacements.

The recalled product

Product
PANTOPRAZOLE SODIUM (PANTOPRAZOLE SODIUM)
Brand
PANTOPRAZOLE SODIUM
Affected units
66,100

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (1)

  • Lot # CPO170035

Distribution

Distributed nationwide across the United States.